HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 09/13/2012 -- PURE Bioscience, (NCM:PURE) is very active today and traded between $1.08 - 1.18 with total traded volume of 2702685 shares. At a current price of 1.135, PURE is -0.235 - -17.15% from the previous close of $1.37. Moreover, At Current Market Price, PURE is in distance of -59.55% from its 50-day Moving Average price of $2.806 and -57.76% from its 200-day Moving Average price of $2.687. PURE Bioscience, Inc. (PURE - Analyst Report) announced the pricing of an underwritten public offering of 3,784,000 shares of its common stock, offered at a price to the public of $1.10 per share. The gross proceeds to PURE from this offering are expected to be $4,162,400, before deducting the underwriting discount and other estimated offering expenses payable by PURE. PURE has granted the underwriters a 45-day option to purchase at the public offering price up to an aggregate of 567,600 additional shares of common stock to cover overallotments, if any. The offering is expected to close on or about September 17, 2012, subject to customary closing conditions. This offering will boost the Company’s balance sheet immediately. As we pointed out before, cash burn is our chief concern. As of April 30, 2012, the Company had cash and cash equivalents of approximately $0.3 million. With proceeds from this offering, the Company should have cash on hand of approximately $4 million, which will last through the end of 2012.
Find Out Where Pure is Headed?
MEDIWARE Informat (NCM:MEDW) is very active today and traded between $21.84 - 21.92 with total traded volume of 1519041 shares. At a current price of 21.86, MEDW is +6.11 - +38.79% from the previous close of $15.75. Moreover, At Current Market Price, MEDW is in distance of +52.05% from its 50-day Moving Average price of $14.3769 and +50.49% from its 200-day Moving Average price of $14.5262. Mediware Information Systems, Inc. (Mediware) licenses, implements and supports clinical and performance management information solutions and other services to healthcare facilities. It licenses its blood and biologics management solutions to hospitals. Mediware licenses its blood donor recruitment and management solutions to blood donor and plasma donor centers through its Blood Center Technologies business group.Mediware Information Systems Inc. MEDW +38.79% jumped 39% after its board approved a $22-a-share buyout offer made by private-equity firm Thoma Bravo LLC in a deal valued at about $195 million. The price amounts to a premium of about 40% over the health-care-software maker’s Tuesday closing price of $15.75 a share.
Find Out The Rally Signal and Target Price of MEDW?
Teekay Offshore P (NYSE:TOO) is -1.56 - -5.42% from the previous close of $28.76. It traded between $27.18 - 27.51 with total traded volume of 6685075 shares. Keep a close eye on TOO, as the stock has been showing unusual moves over the past weeks. At Current market price, TOO has recovered +22.52% from its 52-week Low of 22.20 and has Pulled back -9.75% from its 52-week high of 30.14. Teekay Offshore Partners L.P. (NYSE:TOO) declined 4.55 % to $ 27.45 on a traded volume of 2.75 million shares. The Company announced public offering of 7,400,000 common units in a public offering at $27.65 per unit. Teekay Offshore Partners has granted the underwriters a 30 day option to purchase up to 1,110,000 additional common units. The net proceeds from the public offering is expected to be used to partially finance the purchase price of the Voyageur Spirit FPSO unit. The joint book-running managers for this offering are Citigroup, BofA Merrill Lynch and RBC Capital Markets.
Will TOO Stop its Uptrend or Start Downtrend From here : Find Out Here
Coffee Holding Co (NCM:JVA) reported EPS of -0.04. For the Current Fiscal year, the company is expected to report EPS of 0.41. For the Next Quarter and Next Year, the company is expected to report EPS of 0.21 and 0.76 respectively. At Current Market Price, JVA is in distance of +40.64% from its 50-day Moving Average price of $6.186 and +12.83% from its 200-day Moving Average price of $7.7108. Shares of Coffee Holding Co. Inc. (NASDAQ: JVA), an integrated wholesale coffee roaster and dealer in the U.S., surged in trading on Wednesday after the company reported strong third-quarter financial results. For the third quarter ended July 31, 2012, JVA reported net income of $1.231 million, or $0.19 per share, compared to net income of $168,236, or $0.03 per share reported for the same period in the previous year. JVA’s third-quarter profit beat JVA’s net sales for the quarter were $44.48 million, compared to $35.76 million reported for the same period in the previous year. The increase reflects higher sales volume compared to the third quarter of fiscal 2011. JVA also said that the previously announced quarterly cash dividend of $0.03 per share will be paid on October 29, 2012 to shareholders on record as of close of business on October 16, 2012.
Will JVA Breaks its Old High and Creat New One : Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)